Insider · CIK 0001659625

Gosebruch Henry O

Reports to the SEC for 5 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001659625

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-19	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+6,662 sh	—	—	6,662
2025-05-21	ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−92.2K sh	—	—	0
2025-05-21	ACELYRIN, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2025-05-21	ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−155K sh	—	—	0
2024-06-07	ACELYRIN, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+92.2K sh	—	—	92,158
2024-02-14	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+160K sh	—	—	160,000
2024-02-14	NMRANeumora Therapeutics, Inc.A Award	Director, President & CEO	AAward	+80K sh	—	—	462,345
2023-09-19	NMRANeumora Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+15K sh	$12.62	+$189K	15,000
2023-05-09	ACELYRIN, Inc.P Purchase	Director	PPurchase	+50K sh	$18.00	+$900K	50,000
2023-05-09	ACELYRIN, Inc.Director Stock Option (right to buy)J Other	Director	JOther	+155K sh	—	—	155,450
2023-05-09	ACELYRIN, Inc.Director Stock Option (right to buy)J Other	Director	JOther	−155K sh	—	—	0
2022-05-26	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2022-05-16	ABBVAbbVie Inc.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+84K sh	$54.86	+$4.61M	100,583
2022-05-16	ABBVAbbVie Inc. · Option (Right to Buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−84K sh	$54.86	−$4.61M	0
2022-05-16	ABBVAbbVie Inc. · Option (Right to Buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−84K sh	$54.86	−$4.61M	0
2022-05-16	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−84K sh	$155.00	−$13M	41,623
2022-05-16	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−84K sh	$155.00	−$13M	16,623
2022-05-16	ABBVAbbVie Inc.M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+84K sh	$54.86	+$4.61M	125,583
2022-03-01	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−15.7K sh	$146.81	−$2.31M	62,767
2022-03-01	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−1,101 sh	$149.14	−$164K	41,623
2022-03-01	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−8,303 sh	$148.62	−$1.23M	42,724
2022-03-01	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−5,596 sh	$147.54	−$826K	51,027
2022-03-01	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−15.7K sh	$146.81	−$2.31M	25,890
2022-03-01	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−4,000 sh	$148.71	−$595K	16,723
2022-03-01	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−100 sh	$149.38	−$14.9K	53,500
2022-03-01	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−100 sh	$149.38	−$14.9K	16,623
2022-03-01	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−4,000 sh	$148.71	−$595K	53,600
2022-03-01	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−5,167 sh	$147.60	−$763K	57,600
2022-03-01	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−5,167 sh	$147.60	−$763K	20,723
2022-02-25	ABBVAbbVie Inc.F Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−30.2K sh	$149.54	−$4.51M	56,623
2022-02-17	ABBVAbbVie Inc.A Award	EVP, Chief Strategy Officer	AAward	+7,972 sh	—	—	63,356
2022-02-17	ABBVAbbVie Inc.A Award	EVP, Chief Strategy Officer	AAward	+36.7K sh	—	—	55,384
2022-02-17	ABBVAbbVie Inc. · Option (right to buy)A Award	EVP, Chief Strategy Officer	AAward	+30.6K sh	—	—	30,647
2022-02-17	ABBVAbbVie Inc.A Award	EVP, Chief Strategy Officer	AAward	+8,701 sh	—	—	86,779
2022-02-17	ABBVAbbVie Inc.A Award	EVP, Chief Strategy Officer	AAward	+14.7K sh	—	—	78,078
2021-09-07	ABBVAbbVie Inc.G Gift	EVP, Chief Strategy Officer	GGift	+30K sh	—	—	78,500
2021-09-07	ABBVAbbVie Inc.G Gift	EVP, Chief Strategy Officer	GGift	−30K sh	—	—	18,711
2021-05-27	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-02-28	ABBVAbbVie Inc.F Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−22.8K sh	$107.74	−$2.46M	48,711
2021-02-18	ABBVAbbVie Inc.A Award	EVP, Chief Strategy Officer	AAward	+22.3K sh	—	—	42,293
2021-02-18	ABBVAbbVie Inc. · Option(right to buy)A Award	EVP, Chief Strategy Officer	AAward	+49.1K sh	—	—	49,068
2021-02-18	ABBVAbbVie Inc.A Award	EVP, Chief Strategy Officer	AAward	+14.7K sh	—	—	71,544
2021-02-18	ABBVAbbVie Inc.A Award	EVP, Chief Strategy Officer	AAward	+7,972 sh	—	—	56,820
2021-02-18	ABBVAbbVie Inc.A Award	EVP, Chief Strategy Officer	AAward	+6,555 sh	—	—	48,848
2020-12-31	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,339 sh	$2.22	+$11.9K	5,339
2020-11-20	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−33.1K sh	$99.49	−$3.29M	20,006
2020-11-20	ABBVAbbVie Inc.S Sale	EVP, Chief Strategy Officer	SSale	−6,900 sh	$98.83	−$682K	53,106
2020-09-30	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,490 sh	$2.16	+$11.9K	5,490
2020-06-30	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+4,051 sh	$2.68	+$10.8K	4,051
2020-05-20	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Aug 274
Gosebruch Henry O0001659625-26-000011
SEC(opens sec.gov)
May 234
Gosebruch Henry O0001962918-25-000058
SEC(opens sec.gov)
Jun 114
Gosebruch Henry O0001962918-24-000091
SEC(opens sec.gov)
Feb 164
Gosebruch Henry O0001610717-24-000065
SEC(opens sec.gov)
Sep 194
Gosebruch Henry O0001610717-23-000290
SEC(opens sec.gov)
May 114
Gosebruch Henry O0001209191-23-028878
SEC(opens sec.gov)
May 314
Gosebruch Henry O0001415889-22-005908
SEC(opens sec.gov)
May 204/A
Gosebruch Henry O0001179110-22-003107
SEC(opens sec.gov)
May 204/A
Gosebruch Henry O0001179110-22-003108
SEC(opens sec.gov)
May 184
Gosebruch Henry O0001179110-22-003076
SEC(opens sec.gov)

Companies

Address

C/O ANI PHARMACEUTICALS, INC. 104 CARNEGIE CENTER, SUITE 300

PRINCETON, NJ, 08540